Search research articles
Contact Us
Filters
Showing results (31-40 of 103) with videos related to
Page
of 11
Sort By:
Cancers
|
February 25, 2023
New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
Ezequiel Mauro, Joana Ferrer-Fàbrega, Tamara Sauri, et al.
Radiology and Oncology
|
July 1, 2022
Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR
Carla Caparroz, Alejandro Forner, Jordi Rimola, et al.
European Radiology
|
July 2, 2020
Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid
Jordi Rimola, Anna Darnell, Ernest Belmonte, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies
Mar Ros-Buxó, Ezequiel Mauro, Tamara Sauri, et al.
Journal of Hepatology
|
April 8, 2014
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
Maria Reig, Ferran Torres, Carlos Rodriguez-Lope, et al.
Journal of Hepatology
|
February 9, 2012
Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI
Jordi Rimola, Alejandro Forner, Silvia Tremosini, et al.
Hepatology (Baltimore, Md.)
|
June 22, 2013
Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design
Maria Reig, Jordi Rimola, Ferran Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 4, 2024
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma
Ezequiel Mauro, Manuel Rodríguez-Perálvarez, Antonio D'Alessio, et al.
Journal of Clinical & Translational Endocrinology
|
October 10, 2024
Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study
Arunkumar Krishnan, Carolin V Schneider, Hendrik-Tobias Arkenau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 12, 2019
Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis
Carmen Ayuso, Alejandro Forner, Anna Darnell, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 103) with videos related to
Sort By:
Page
of 11
Cancers
|
February 25, 2023
New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
Ezequiel Mauro, Joana Ferrer-Fàbrega, Tamara Sauri, et al.
Radiology and Oncology
|
July 1, 2022
Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR
Carla Caparroz, Alejandro Forner, Jordi Rimola, et al.
European Radiology
|
July 2, 2020
Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid
Jordi Rimola, Anna Darnell, Ernest Belmonte, et al.
Current Oncology (Toronto, Ont.)
|
July 26, 2024
Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies
Mar Ros-Buxó, Ezequiel Mauro, Tamara Sauri, et al.
Journal of Hepatology
|
April 8, 2014
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
Maria Reig, Ferran Torres, Carlos Rodriguez-Lope, et al.
Journal of Hepatology
|
February 9, 2012
Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI
Jordi Rimola, Alejandro Forner, Silvia Tremosini, et al.
Hepatology (Baltimore, Md.)
|
June 22, 2013
Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design
Maria Reig, Jordi Rimola, Ferran Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 4, 2024
New Scenarios in Liver Transplantation for Hepatocellular Carcinoma
Ezequiel Mauro, Manuel Rodríguez-Perálvarez, Antonio D'Alessio, et al.
Journal of Clinical & Translational Endocrinology
|
October 10, 2024
Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study
Arunkumar Krishnan, Carolin V Schneider, Hendrik-Tobias Arkenau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 12, 2019
Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis
Carmen Ayuso, Alejandro Forner, Anna Darnell, et al.
Page
of 11